trending Market Intelligence /marketintelligence/en/news-insights/trending/iz-_o_7gwwik3zhe8ycdcg2 content esgSubNav
In This List

Roche gets US FDA approval for blood testing device

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Roche gets US FDA approval for blood testing device

Roche Holding AG received the 510(k) approval from the U.S. Food and Drug Administration for cobas m 511, a blood testing device.

The device is used for identifying, counting and categorizing white blood cells, red blood cells and platelets and then presenting the digital images of the cell types.